Author:
Baxter I.,Rogers A.,Eastell R.,Peel N.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference18 articles.
1. Eastell R (2003) Bone turnover markers: their place in the investigation of osteoporosis. In: Orwoll E, Bliziotes M (eds) Oteoporosis. Pathophysiology and clinical management. Contemporary endocrinology. Humana, Totowa, pp 185–197
2. Seibel MJ (2006) Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis. Clin Biochem Rev 27:123–138
3. Clowes JA, Peel NF, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89(3):1117–1123
4. Braga de Castro Machado A, Hannon R, Hannon R, Eastell R (1999) Monitoring alendronate therapy for osteoporosis. J Bone Miner Res 14(4):602–608. doi: 10.1359/jbmr.1999.14.4.602
5. Rogers A, Glover SJ, Eastell R (2009) A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy. Bone 45(6):1044–1052. doi: 10.1016/j.bone.2009.07.089
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献